Search

Coloplast A-S (Class B)

Închisă

538.6 -0.55

Rezumat

Modificarea prețului

24h

Curent

Minim

537.6

Maxim

544

Indicatori cheie

By Trading Economics

Venit

70M

875M

Vânzări

2M

7B

P/E

Medie Sector

33.065

90.422

EPS

3.88

Randament dividend

4.26

Marjă de profit

12.572

Angajați

16,744

EBITDA

2B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.26%

2.13%

Următoarele câștiguri

6 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-2.3B

120B

Deschiderea anterioară

539.15

Închiderea anterioară

538.6

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 ian. 2026, 20:14 UTC

Achiziții, Fuziuni, Preluări

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30 ian. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30 ian. 2026, 23:41 UTC

Market Talk

Deckers Outdoor Seen as Undervalued -- Market Talk

30 ian. 2026, 23:12 UTC

Achiziții, Fuziuni, Preluări

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30 ian. 2026, 22:20 UTC

Câștiguri

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30 ian. 2026, 22:10 UTC

Market Talk

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30 ian. 2026, 21:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

30 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 ian. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

30 ian. 2026, 21:42 UTC

Câștiguri

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ian. 2026, 21:36 UTC

Câștiguri

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30 ian. 2026, 21:33 UTC

Câștiguri

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30 ian. 2026, 20:42 UTC

Câștiguri

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ian. 2026, 20:37 UTC

Achiziții, Fuziuni, Preluări

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

30 ian. 2026, 20:20 UTC

Market Talk

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

30 ian. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

30 ian. 2026, 19:52 UTC

Câștiguri

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

30 ian. 2026, 19:29 UTC

Market Talk
Câștiguri

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

30 ian. 2026, 19:09 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 ian. 2026, 19:09 UTC

Market Talk

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

30 ian. 2026, 19:07 UTC

Market Talk

Canada Performing Well Below Economic Potential -- Market Talk

30 ian. 2026, 18:46 UTC

Câștiguri

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

30 ian. 2026, 18:34 UTC

Câștiguri

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat